Alpha-5 beta-1 inhibitors

US11530180B2 · kind B2 · utility

Assignees

• The Regents of the University of California · US
• Shanghai ChemPartner Co., Ltd. · US

Inventors

• Dean Sheppard · Oakland, US
• William F. DeGrado · Media, US
• Hyunil Jo · Lafayette, US
• Aparna Sundaram · San Francisco, US
• Richard Thomas Beresis · Shanghai, CN

Key dates

• Filing date: Dec 9, 2020
• Grant date: Dec 20, 2022
• Expiry date: Dec 9, 2040

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07C2602/10
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The disclosure provides, inter alia, alpha-5 beta-1 inhibitors, pharmaceutical compositions comprising alpha-5 beta-1 inhibitors, methods for treating diseases using alpha-5 beta-1 inhibitors, and processes for making alpha-5 beta-1 inhibitors.